ArticleNeurosurgical review2024
Letter to the editor: Systematic review on neuroprotective agents in spinal cord injury.
Article in Neurosurgical review, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Letter to editor: comment on, "Imaging manifestations of papillary glioneuronal tumors".Neurosurgical review · 2024Article
- Comment on, "Computed tomography based evaluation of the association between sphenoid sinus pneumatization patterns and variations of adjacent bony structures in relation to age and gender".Neurosurgical review · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A thorough summary of recent findings on neuroprotective tactics for spinal cord injury (SCI) can be found in the paper "An Updated Systematic Review of Neuroprotective Agents in the Treatment of Spinal Cord Injury". This review highlights the diverse neuroprotective drugs' mechanisms of action, effectiveness, and translational potential. It also emphasizes the necessity of carefully planned clinical studies to close the gap between preclinical data and clinical applications. The authors provide priceless ideas for improving SCI treatment by carefully examining the most recent clinical and preclinical research. For doctors and researchers committed to enhancing the therapeutic results for people with spinal cord injuries, this review is a vital resource.
Indexed as
Identifiers
39180651What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.